Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medulloblastoma × Cytarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 502 Leukemia 258 Precursor Cell Lymphoblastic Leukemia-Lymphoma 202 Lymphoma 144 Myelodysplastic Syndromes 97 Burkitt Lymphoma 80 Leukemia, Monocytic, Acute 78 Lymphoma, Non-Hodgkin 76 Congenital Abnormalities 76 Leukemia, Myelomonocytic, Acute 74 Leukemia, Erythroblastic, Acute 69 Lymphoma, Large B-Cell, Diffuse 68 Leukemia, Megakaryoblastic, Acute 66 Lymphoma, Mantle-Cell 61 Recurrence 59 Lymphoma, Follicular 42 Leukemia, Myelomonocytic, Chronic 41 Hodgkin Disease 40 Leukemia, Biphenotypic, Acute 37 Lymphoma, Large-Cell, Immunoblastic 33 Anemia, Refractory, with Excess of Blasts 32 Myeloproliferative Disorders 30 Leukemia, Lymphocytic, Chronic, B-Cell 30 Blast Crisis 29 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 23 Leukemia, Myeloid, Chronic-Phase 21 Leukemia, Eosinophilic, Acute 21 Lymphoma, B-Cell, Marginal Zone 20 Leukemia, Basophilic, Acute 20

Interventions

Cyclophosphamide 32 Temozolomide 30 Filgrastim 24 Carboplatin 23 Etoposide 22 Vincristine 18 Radiotherapy 18 Cisplatin 18 Magnetic Resonance Spectroscopy 15 Thiotepa 13 Irinotecan 12 Granulocyte Colony-Stimulating Factor 11 Peripheral Blood Stem Cell Transplantation 10 Melphalan 9 Lomustine 9 Topotecan 8 Specimen Handling 8 Methotrexate 8 etoposide phosphate 7 Radiation 7 X-Rays 6 Phantoms, Imaging 6 Biopsy 6 sonidegib 5 sargramostim 5 Platinum 5 Nuclear Medicine Department, Hospital 5 Busulfan 5 Bevacizumab 5 1,2-diaminocyclohexaneplatinum II citrate 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01356290 2026-02-23

MEMMAT

Medical University of Vienna

Phase 2 Recruiting

Ependymoma, Medulloblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡